Immune Response Dynamics and Biomarkers in COVID-19 Patients.
Maral RanjbarRuth P CusackChristiane E WhetstoneDanica L BristerJennifer WattieLesley WiltshireNadia AlsajiJennifer Le RouxEric ChengThivya SrinathanTerence HoRoma SehmiPaul M O'ByrneMaryonne Snow-SmithMichelle A MakiyaAmy D KlionMyLinh DuongGail M GauvreauPublished in: International journal of molecular sciences (2024)
Attenuated eosinophil activity alongside elevated chemokine and cytokine levels during active infection, highlights the complex interplay of immune mediators in the pathogenesis COVID-19 and underscores the need for further investigation into immune biomarkers and treatment strategies.